PatientSpotlight, by PanaceaIntelPatientSpotlight
SignalNEWApr 30, 20261 min read

Vaping-associated lung disease as a recognised category

EVALI (e-cigarette and vaping-associated lung injury) and chronic bronchiolitis from vaping are now recognised pulmonology diagnostic categories.

Vaping-associated lung disease has matured from acute outbreak (the 2019 EVALI cluster) into a recognised chronic-bronchiolitis category in pulmonology. The diagnostic infrastructure is still being built; primary-care pulmonology underestimates prevalence in younger patients with unexplained respiratory symptoms. As vaping prevalence stabilises, so does the long-tail clinical picture.

Continue reading

Full intelligence on PanaceaIntel

PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.

New to PanaceaIntel? Request access and the team will reply within one working day.

Related

DiagnosisPatient journeyPolicy
← Back to Signals
PanaceaIntelPublished by PatientSpotlight, by PanaceaIntel.